Medication info
Wibisd Tablets

Wibisd Tablets

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Tripotassium Bismuth Dicitrate›200mg / 1 tabletRanitidine Hydrochloride›168mg / 1 tabletSucralfate Hydrate›600mg / 1 tablet
Manufacturer / importer
Hanol Bio Pharma Co., Ltd.
Appearance
Greenish rectangular film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201507503 · Approved 2015.10.30

This product's status changed to Approval withdrawn on 2023.12.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of ulcers and acid-related disorders (gastritis, reflux esophagitis, etc.); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults Take 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 1 tablet twice daily or 2 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs), or for the prevention of gastric and duodenal ulcers during long-term NSAID treatment. Conditions caused by NSAID treatment generally heal within 4 weeks, and ulcers generally heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, take 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 1 tablet twice daily or 2 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment at a dose of 1 tablet 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and take 1 tablet twice daily. 5) Premedication (prevention of Mendelson syndrome) Take 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also take 1 tablet on the night before surgery.

Ingredients

Manufacturer
Hanol Bio Pharma Co., Ltd.

Efficacy & effects

Treatment of ulcers and acid-related disorders (gastritis, reflux esophagitis, etc.); prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcers
  • gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs
View approved original text

This medicine is used to treat ulcers in the stomach and duodenum, gastritis, and conditions like Zollinger-Ellison syndrome that involve excessive gastric acid secretion. It also aids in the treatment of gastroesophageal reflux disease and is used preoperatively to prevent Mendelson's syndrome. It is effective for treating ulcers that may arise post-surgery and ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This drug protects the gastric mucosa and reduces inflammation, improving symptoms. Therefore, it can be safely used for various gastric-related diseases.

How to take

Adult dose

○ Adults Take 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 1 tablet twice daily or 2 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs), or for the prevention of gastric and duodenal ulcers during long-term NSAID treatment. Conditions caused by NSAID treatment generally heal within 4 weeks, and ulcers generally heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, take 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 1 tablet twice daily or 2 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment at a dose of 1 tablet 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and take 1 tablet twice daily. 5) Premedication (prevention of Mendelson syndrome) Take 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also take 1 tablet on the night before surgery.

Precautions

This drug should not be used in patients with severely impaired kidney function or those on dialysis. Additionally, it is safe not to administer this drug to patients who have had allergic reactions to it or its ingredients. This drug is also not recommended for patients with a history of acute porphyria, which is a rare condition. It is advised not to administer to women who are pregnant or may become pregnant, as well as to premature or newborn infants. Patients on diets that restrict potassium intake should also avoid this drug. Patients with compromised liver function, those with a history of drug allergic reactions, elderly patients, and patients with kidney issues should exercise caution when using this medication. When taken alongside non-steroidal anti-inflammatory drugs, especially elderly patients or those with a history of peptic ulcers need regular monitoring. This drug can mask symptoms of stomach cancer, so patients with gastric ulcers or those over middle age who have newly developed or changed dyspeptic symptoms should confirm whether malignancy is present before treatment. For patients with gastric or duodenal ulcers who test positive for Helicobacter pylori, eradication treatment is necessary. Patients in intensive care units may develop gastric stones, hence caution is necessary. Patients with hypophosphatemia should be cautious as the aluminum component in this drug can interfere with phosphate absorption. Patients with swallowing difficulties may experience respiratory complications after taking this drug, thus should be careful. Symptoms such as shock, skin rash, hives, or difficulty breathing due to allergic reactions may occur, so if any unusual symptoms arise, discontinue use immediately and consult a healthcare professional. Blood tests may show decreased white blood cell or platelet counts, and liver function test results can temporarily increase. Cardiovascular side effects such as arrhythmias or vasculitis have also been reported rarely. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, and the color of the stool may change; however, this does not require special treatment. Severe dizziness, drowsiness, confusion, and seizures may occur as rare neurological symptoms, so inform a healthcare professional immediately if these symptoms appear. Muscle pain or joint pain can occur, and in severe cases, rhabdomyolysis can cause muscle tissue damage, requiring caution. Skin-related side effects such as rashes or hair loss may also occur rarely. It is advisable not to use this drug for an extended period, and if no therapeutic effect is observed, switching to another medication is preferable. Elderly patients or those with chronic pulmonary disease, diabetes, and reduced immunity may have an increased risk of pneumonia while taking this medication, so caution is warranted. If dizziness or drowsiness occurs after administration, it is safer to avoid driving or operating dangerous machinery. This drug may interact with other medications, so if taking anticoagulants or certain antibiotics or anticonvulsants, inform healthcare providers and manage carefully. It is safest not to use this drug in pregnant or nursing women. Safety in children has not been sufficiently confirmed, so administration should be avoided if possible. In cases of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and blood dialysis may be beneficial in some cases. This drug suppresses gastric acid secretion, which can promote bacterial growth in the stomach; therefore, regular monitoring, including eye exams, is necessary for long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 58 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • aplastic anemia
  • acquired immunohemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundiced hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusional state
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • malaise
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbance
  • hypertrophic myoclonus
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • mild erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • blackening of the tongue
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This way, the medication's effectiveness can be preserved for a longer time.

Appearance and packaging

Appearance

Greenish rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.